Tirzepatide (Mounjaro, Zepbound) activates GLP-1 and GIP receptors
Your primary care physician, endocrinologist, or an expert specializing in diabetes management can assess your health status and determine whether youre a good candidate for the drug
Patients considering these treatments should discuss their individual risk profile with their prescribing clinician, particularly if they have a history of pancreatic disease
Donts: Do Not Take GLP-1 Medications While Pregnant Due to unknown human effects, its best to avoid them entirely during pregnancy
Focus on: Beta-glucans: Found in oats and barley
Most people begin noticing appetite suppression within 1 to 2 weeks, measurable weight loss within 2 to 4 weeks, and more significant results within 8 to 12 weeks